← Live signals
CHRDNet selling

Insider activity on CHRD over the last 12 months.

Open-market buys
Open-market sells
$1.3M
Distinct insiders
2
Filings (12mo)
3
Email me when an insider trades CHRD
Free alert, minutes after the SEC filing lands. One-click unsubscribe.

Price & insider trades

Where insiders bought and sold against CHRD's price — tap a bubble for the P&L since.

Insider buyInsider sellClose · 12mo · $111.59 now
Tap a bubble to see the insider's P&L since they traded.

Graded signals

AI-scored insider events on CHRD — tap any signal for the full read.

NEUTRAL30d -13.6% vs SPY
CHRD EVP sells $186K near 90-day high in first-ever trade
49d ago

EVP Darrin Henke sold $186,000 in CHRD shares, reducing his stake by 5.7% at a price just 3.0% below the 90-day high. This first-time sale near a recent peak lacks a supporting cluster of other buyers, making it more likely routine than a strong directional signal.

Where it could go — Analyst mean target not provided; bear case if stock breaks the 30-day low of $119.92.

Conviction 3/10LOW importance50% confidence
NEUTRAL30d +0.2% vs SPY
Brooks Douglas E sells 3,000 CHRD shares at $137.79; first trade on file
56d ago

Director Brooks Douglas E executed a Code-S open-market sale of 3,000 shares at $137.79 on 2026-05-07, reducing holdings by 11.2% ($413K notional value). This is the insider's first Form 4 filing on record—no prior Code-P buys or Code-S sales exist, eliminating any historical pattern baseline for this individual. The sale occurred 43% above the 90-day low ($96.39) and 8.4% below the 90-day high ($150.50), with 25 analysts maintaining STRONG BUY consensus (21 buy / 4 hold / 0 sell), and zero other insider buyers in the past 60 days.

Where it could go — Without prior trading history for this insider or comparable CHRD Code-S signals in the dataset, directional conviction is low; if the analyst consensus holds and no material negative catalyst emerges, the stock's historical support near $120 (30d low) would need to break to invalidate the bull case implied by 84% buy-side coverage.

Conviction 3/10LOW importance45% confidence
NEUTRAL30d -1.8% vs SPY
Brooks Douglas E sells 3,000 CHRD shares at $137.79; first trade on file
56d ago

Director Brooks Douglas E executed a Code-S open-market sale of 3,000 shares at $137.79 on 2026-05-07, reducing holdings by 11.2% ($413K notional value). This is the insider's first Form 4 filing on record—no prior Code-P buys or Code-S sales exist, eliminating any historical pattern baseline for this individual. The sale occurred 43% above the 90-day low ($96.39) and 8.4% below the 90-day high ($150.50), with 25 analysts maintaining STRONG BUY consensus (21 buy / 4 hold / 0 sell), and zero other insider buyers in the past 60 days.

Where it could go — Without prior trading history for this insider or comparable CHRD Code-S signals in the dataset, directional conviction is low; if the analyst consensus holds and no material negative catalyst emerges, the stock's historical support near $120 (30d low) would need to break to invalidate the bull case implied by 84% buy-side coverage.

Conviction 3/10LOW importance45% confidence
NEUTRAL30d -1.6% vs SPY
Brooks Douglas E sells 3,000 CHRD shares at $137.79; first trade on file
56d ago

Director Brooks Douglas E executed a Code-S open-market sale of 3,000 shares at $137.79 on 2026-05-07, reducing holdings by 11.2% ($413K notional value). This is the insider's first Form 4 filing on record—no prior Code-P buys or Code-S sales exist, eliminating any historical pattern baseline for this individual. The sale occurred 43% above the 90-day low ($96.39) and 8.4% below the 90-day high ($150.50), with 25 analysts maintaining STRONG BUY consensus (21 buy / 4 hold / 0 sell), and zero other insider buyers in the past 60 days.

Where it could go — Without prior trading history for this insider or comparable CHRD Code-S signals in the dataset, directional conviction is low; if the analyst consensus holds and no material negative catalyst emerges, the stock's historical support near $120 (30d low) would need to break to invalidate the bull case implied by 84% buy-side coverage.

Conviction 3/10LOW importance45% confidence

Recent insider trades

The open-market buys and sells filed on CHRD.

Henke Darrin J.
EVP and COO · 2026-05-15
$186K
sell
Brooks Douglas E
Director · 2026-05-07
$1.1M
sell